From a thousand seedlings to a market cultivar: breeding and selection

TL;DR

• Breeding is mostly selection: one single phenotype is picked out of large seedling populations.
• Selection criteria: yield, cannabinoid and terpene profile, flowering time, mould resistance and cutting performance.
• The chosen cut is kept as a mother plant; tissue culture secures it long-term against viroids and degeneration.
• In Switzerland low-THC varieties are handled through the variety catalogue; UPOV plant variety protection is possible but rarely used.

The breeding cycle in practice

It starts with a target: for instance a chemotype III profile high in CBD and low in THC, short flowering time and botrytis resistance. Suitable parents are then crossed and a large seedling population is grown out.

During selection plants are continuously culled: flowering too late, poor yield, wrong aroma, mould-prone. A few candidates remain, get lab-analysed and are confirmed in a second run.

Mother plants, tissue culture and clean stock

A selected cut is kept as a mother plant in vegetative phase. Over years it can accumulate viroids (such as HLVd) or pests, slowly degrading yield and resin — the frequently cited 'degeneration'.

Professional operations therefore bank key genetics in tissue culture (meristem culture) and regenerate clean mother plants from it. That is the difference between a hobby stock and dependable production genetics.

Legal framework in Switzerland

For hemp below the THC threshold, ordinary agricultural rules apply and varieties can be listed in variety catalogues. Breeding work with plants above the threshold requires an FOPH authorisation or runs inside the pilot trials.

Plant variety protection (the UPOV system) would be available but is barely used — in practice the industry protects genetics through trademarks, secrecy and exclusive clone distribution.

What separates real breeding from marketing

A new cultivar name does not mean real breeding work exists behind it. What counts: documented parent lines, several generations of selection, reproducible lab values across multiple batches and an explicit account of the selection criteria.

For consumers that is the practical test: anyone who cannot explain where a genetic came from is selling a name, not a breeding programme.

Phenotypic plasticity and environmental influences

Breeding work relies heavily on the distinction between genotype and phenotype. While a plant's genetic makeup is fixed by crossbreeding, the environment determines how these genetic traits manifest physically. Factors such as light spectrum, temperature profiles, humidity, and nutrient supply massively influence growth, flower structure, and the final concentration of active ingredients. A selected cutting that delivers outstanding results in a controlled indoor facility can exhibit completely different characteristics in the Swiss outdoor environment or greenhouse. This phenotypic plasticity requires comprehensive test series under various cultivation conditions before genetics are released for commercial propagation.

For professional breeders, this means that selection is not completed after a single run. Only when a phenotype proves its stability over several generations and in different substrates is it considered reliable. In particular, susceptibility to molds such as botrytis or powdery mildew often only becomes apparent under real Swiss weather conditions with wet autumn weeks. Anyone who selects exclusively under artificial light risks significant crop losses in outdoor or greenhouse cultivation, as the plant's natural resilience remains untested.

• Distinction between the fixed genotype and the variable phenotype depending on environmental conditions.
• Influence of light spectrum, temperature profile, and humidity on terpene and cannabinoid synthesis.
• Necessity of multi-part test series in indoor, greenhouse, and outdoor cultivation.
• Early detection of weaknesses such as a lack of mold resistance under high humidity.

Analytics and chemometric selection

Modern cannabis breeding no longer relies solely on the breeder's trained eye or sense of smell. Chemometric selection utilizes highly sophisticated laboratory analyses to determine the exact profile of active ingredients. High-performance liquid chromatography (HPLC) and gas chromatography (GC) are used to measure the precise ratios of cannabinoids and terpenes. This makes it possible to selectively target phenotypes that exhibit a balanced ratio or accumulate rare, highly sought-after terpenes in high concentrations. Without this precise laboratory data, selection remains an inaccurate guessing game that fails to meet the modern demands of the market.

In addition to the primary active ingredients, the stability of the chemotype is increasingly becoming a focus of laboratory analytics. Breeders must ensure that the chemical composition remains homogeneous across different harvest cycles. Fluctuations in active ingredient content can lead to regulatory issues, particularly when used in the medical sector or within the framework of controlled pilot trials. Furthermore, laboratory selection filters out plants that exhibit an undesirable tendency to accumulate heavy metals or other contaminants from the soil, which severely compromises the quality of the final products.

• Use of HPLC and gas chromatography for the precise determination of the chemical profile.
• Targeted selection of phenotypes with specific terpene and cannabinoid ratios.
• Ensuring the homogeneity of active ingredients across consecutive harvest cycles.
• Exclusion of lines with undesirable traits, such as a tendency to accumulate contaminants.

Breeding objectives for the Swiss market

The legal framework in Switzerland shapes breeding objectives in a unique way. Since the limit for over-the-counter sales is below 1% total THC, domestic breeding focuses primarily on CBD- and CBG-rich strains that reliably comply with this limit. A stable chemotype III, which does not exceed the critical threshold of 1% total THC even under stress conditions such as heat or nutrient deficiency, is the primary goal. Since THC content increases correlatively with CBD content, this requires highly precise genetic fine-tuning to maximize the legal limit of CBD without violating the law.

At the same time, breeding projects for THC-rich strains are gaining importance within the framework of Swiss pilot trials and for the medical sector. Here, stricter requirements for standardization and purity apply, which are monitored by Swissmedic and the BAG. Swiss breeders must therefore develop strains that not only exhibit specific active ingredient profiles but are also excellently suited for standardized indoor cultivation under GMP conditions. Adaptation to the short, often humid summers in the Swiss Alpine region also remains a central focus for outdoor projects.

• Focus on strict compliance with the Swiss limit of below 1% total THC for the open market.
• Prevention of THC spikes in CBD-rich strains under environmental stress.
• Development of standardized, homogeneous genetics for medical applications and pilot trials.
• Breeding of resilient strains for the specific climatic conditions of Switzerland.

Risks of inbreeding depression in the breeding process

A frequently underestimated risk in intensive cannabis breeding is so-called inbreeding depression. When breeders cross closely related plants over many generations or repeatedly perform backcrosses to stabilize specific traits, the genetic diversity within the line decreases. This often leads to a gradual loss of vigor, manifested in slower growth, reduced pest resistance, and declining yields. The susceptibility to mutations and hermaphroditism also increases significantly, rendering the genetics useless for commercial use.

To avoid this genetic bottleneck, professional breeding programs must regularly introduce fresh, unrelated genetic material. This process requires a deep understanding of pedigrees and seamless documentation of all crossing steps. The challenge lies in preserving the desired, stabilized traits of the original line while simultaneously restoring the necessary hybrid vigor. Only through strategically planned breeding biology can the long-term performance of a strain be secured.

• Risk of loss of vigor and declining yields due to continued inbreeding and backcrossing.
• Increased risk of hermaphroditism and genetically induced growth anomalies.
• Necessity of targeted introduction of external lines to restore hybrid vigor.
• Importance of seamless pedigree documentation to avoid unintentional inbreeding.

FAQ